FONAR (NASDAQ:FONR) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of FONAR (NASDAQ:FONRGet Rating) in a research report issued on Friday. The brokerage set a “strong-buy” rating on the medical equipment provider’s stock.

Separately, TheStreet lowered FONAR from a “b-” rating to a “c+” rating in a research note on Tuesday, May 17th.

FONAR stock opened at $15.45 on Friday. The stock’s 50-day moving average is $16.95 and its 200-day moving average is $16.64. The company has a debt-to-equity ratio of 0.01, a quick ratio of 7.90 and a current ratio of 8.07. FONAR has a 12 month low of $14.24 and a 12 month high of $19.32.

FONAR (NASDAQ:FONRGet Rating) last released its quarterly earnings data on Monday, May 16th. The medical equipment provider reported $0.32 EPS for the quarter. The company had revenue of $24.57 million for the quarter. FONAR had a return on equity of 8.66% and a net margin of 10.96%.

Several hedge funds have recently bought and sold shares of FONR. UBS Group AG grew its stake in shares of FONAR by 53,600.0% in the first quarter. UBS Group AG now owns 2,148 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 2,144 shares in the last quarter. Denali Advisors LLC acquired a new stake in shares of FONAR in the fourth quarter valued at about $75,000. Hikari Tsushin Inc. acquired a new stake in FONAR during the 4th quarter valued at approximately $212,000. D. E. Shaw & Co. Inc. grew its stake in FONAR by 21.0% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 15,201 shares of the medical equipment provider’s stock valued at $228,000 after purchasing an additional 2,638 shares in the last quarter. Finally, Citadel Advisors LLC acquired a new stake in FONAR during the 2nd quarter valued at approximately $257,000. Institutional investors and hedge funds own 45.66% of the company’s stock.

FONAR Company Profile (Get Rating)

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment.

Recommended Stories

Receive News & Ratings for FONAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FONAR and related companies with MarketBeat.com's FREE daily email newsletter.